IP Library Granted Patent US 10,150,672
Granted Patent B2
US 10,150,672 · App. 15/321,302 · Granted Dec 11, 2018

Porous calcium deficient hydroxyapatite granules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,150,672
App. No.
15/321,302
Granted
Dec 11, 2018
Kind
B2
Abstract

The method is for producing porous calcium deficient hydroxyapatite granules and comprises the following steps: (a) subjecting granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) to an incubation in an alkaline aqueous solution having a pH-value of less than 10 and containing PO 4 3− ions; whereby the granules of calcium sulfate anhydrous (CSA), calcium sulfate dihydrate (CSD) or calcium sulfate hemihydrate (CSH) comprise interconnected pores with a minimum mean diameter of 3 microns; (b) washing with water the granules obtained after incubation of step a); (c) drying the obtained porous granules of calcium deficient hydroxyapatite; whereby (d) the amount-of PO 4 3− ions present in the incubation of step a) is at least as large as the amount of SO 4 2− ions of the granules used for step (a). The porous calcium deficient hydroxyapatite granules obtained by the invention may be purposefully used as carriers for biologically active substances in particular for proteins.

Claims (4)

1. Porous calcium deficient hydroxyapatite granules comprising a plurality of micropores having a minimum mean diameter of 3 microns, wherein the micropores are interconnected by channels having a mean diameter larger than 1 micron and wherein the micropores have a mean diameter of less than 20 microns.

2. The porous calcium deficient hydroxyapatite granules according to claim 1 , wherein the granules have a composition corresponding to Ca (10-x) (PO 4 ) (6-x) (HPO 4 ) x (OH) (2-x) , where 0<x≤2.

3. The porous calcium deficient hydroxyapatite granules according to claim 1 , wherein the granules have a Ca:P ratio in the range of 1.51 to 1.59.

4. The porous calcium deficient hydroxyapatite granules according to claim 1 , wherein a majority of the porous calcium deficient hydroxyapatite granules have a mean diameter of larger than 50 micrometers.

Assignments (5)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: DE GASPARO, ALEX; VAN GARDEREN, NOEMIE; BOHNER, MARC
To: MATHYS AG BETTLACH
Reel/Frame 043102/0936 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: SEEHERMAN, HOWARD; VANDERPLOEG, ERIC
To: BIOVENTUS, LLC
Reel/Frame 043342/0497 →